Back
Evoke Pharma Vs. Matthews International Industry Stock Comparison
Sell
11
EVOK
Evoke Pharma
Last Price:
4.35
Seasonality Move:
8.87%
Buy
66
MATW
Matthews International
Last Price:
30.85
Seasonality Move:
1.52%
Sell
11
Evoke Pharma (EVOK)
is a Sell
Is Evoke Pharma a Buy, Sell or Hold?
- The current Evoke Pharma [EVOK] share price is $4.33. The Score for EVOK is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
- EVOK is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
66
Matthews International (MATW)
is a Buy
Is Matthews International a Buy, Sell or Hold?
- The current Matthews International [MATW] share price is $30.84. The Score for MATW is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- MATW is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EVOK Stock Price Chart
What is Evoke Pharma's stock price today?
-
The Evoke Pharma share price today is $4.33
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EVOK is experiencing selling pressure, which indicates risk of future bearish movement.
MATW Stock Price Chart
What is Matthews International's stock price today?
-
The Matthews International share price today is $30.84
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MATW is experiencing buying pressure, which is a positive indicator for future bullish movement.
EVOK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.26 | Sell |
| Relative Strength Index (14 RSI): | 38.44 | Sell |
| Chaikin Money Flow: | -36406 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.59 - 6.03) | Sell |
| Bollinger Bands (100): | (4.43 - 6.09) | Sell |
MATW Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.9 | Buy |
| Relative Strength Index (14 RSI): | 84.93 | Buy |
| Chaikin Money Flow: | 345410 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.28 - 25.54) | Buy |
| Bollinger Bands (100): | (22.55 - 26.39) | Buy |
EVOK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.46 | Sell |
| 20-day SMA: | 5.31 | Sell |
| 50-day SMA: | 5.13 | Sell |
| 200-day SMA: | 5.95 | Sell |
| 8-day EMA: | 4.61 | Sell |
| 20-day EMA: | 4.96 | Sell |
| 50-day EMA: | 5.12 | Sell |
| 200-day EMA: | 7.17 | Sell |
MATW Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.94 | Buy |
| 20-day SMA: | 24.26 | Buy |
| 50-day SMA: | 23.29 | Buy |
| 200-day SMA: | 26.19 | Buy |
| 8-day EMA: | 25.74 | Buy |
| 20-day EMA: | 24.52 | Buy |
| 50-day EMA: | 23.98 | Buy |
| 200-day EMA: | 26.71 | Buy |
Evoke Pharma Earnings Growth & EVOK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $22.78 per share, and an increase next year of $4.46 per share.
Matthews International Earnings Growth & MATW Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.74 per share, and a decrease next year of $0.28 per share.
Evoke Pharma Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Matthews International Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||